9/3/2009 9:58:18 AM
SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that it has hired Merriman Curhan Ford as its financial advisor to assist the Company in exploring and evaluating strategic alternatives. At this time, Metabasis has not made a decision to pursue any specific transaction or other strategic alternative, and there can be no assurance that this process will result in any specific transaction or other strategic alternative. Metabasis does not intend to comment further on this process unless and until its Board of Directors has approved a specific transaction or other strategic alternative.
comments powered by